IDH1 and central nervous system cancer: In contrast, oligodendroglioma cases showed near-perfect concordance (97.0%) with the original diagnoses, whereas other IDH1/2-wild-type glioma cases were frequently misclassified as GBM cases (24.8%) or astrocytoma cases (23.3%) prior to molecular analysis (Fig. 2B).